Price David 4
4 · EyePoint Pharmaceuticals, Inc. · Filed Jun 27, 2019
Insider Transaction Report
Form 4
Price David
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-06-25+300,000→ 300,000 totalExercise: $2.65Exp: 2029-02-21→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]The option to purchase vests and becomes exercisable ratably in forty-eight monthly installments which began March 21, 2019